Hayward NK - Search Results

1

Compilation of somatic mutations of the CDKN2 gene in human cancers: non-random distribution of base substitutions.

Pollock PM, Pearson JV, Hayward NK. Pollock PM, et al. Among authors: hayward nk. Genes Chromosomes Cancer. 1996 Feb;15(2):77-88. doi: 10.1002/(SICI)1098-2264(199602)15:2<77::AID-GCC1>3.0.CO;2-0. Genes Chromosomes Cancer. 1996. PMID: 8834170 Review.

2

Evidence for u.v. induction of CDKN2 mutations in melanoma cell lines.

Pollock PM, Yu F, Qiu L, Parsons PG, Hayward NK. Pollock PM, et al. Among authors: hayward nk. Oncogene. 1995 Aug 17;11(4):663-8. Oncogene. 1995. PMID: 7651729

3

CDKN2A/p16 is inactivated in most melanoma cell lines.

Castellano M, Pollock PM, Walters MK, Sparrow LE, Down LM, Gabrielli BG, Parsons PG, Hayward NK. Castellano M, et al. Among authors: hayward nk. Cancer Res. 1997 Nov 1;57(21):4868-75. Cancer Res. 1997. PMID: 9354451

4

CDKN2A is not the principal target of deletions on the short arm of chromosome 9 in neuroendocrine (Merkel cell) carcinoma of the skin.

Cook AL, Pollock PM, Welch J, Walsh MD, Bowman RV, Baumann KC, Hayward NK, Leonard JH. Cook AL, et al. Among authors: hayward nk. Int J Cancer. 2001 Aug 1;93(3):361-7. doi: 10.1002/ijc.1352. Int J Cancer. 2001. PMID: 11433400 Free article.

5

Mutation analysis of the CDKN2A promoter in Australian melanoma families.

Pollock PM, Stark MS, Palmer JM, Walters MK, Aitken JF, Martin NG, Hayward NK. Pollock PM, et al. Among authors: hayward nk. Genes Chromosomes Cancer. 2001 Sep;32(1):89-94. doi: 10.1002/gcc.1170. Genes Chromosomes Cancer. 2001. PMID: 11477665

6

The CDKN2A (p16) gene and human cancer.

Foulkes WD, Flanders TY, Pollock PM, Hayward NK. Foulkes WD, et al. Among authors: hayward nk. Mol Med. 1997 Jan;3(1):5-20. Mol Med. 1997. PMID: 9132280 Free PMC article. Review.

7

CDKN2A mutation in a non-FAMMM kindred with cancers at multiple sites results in a functionally abnormal protein.

Sun S, Pollock PM, Liu L, Karimi S, Jothy S, Milner BJ, Renwick A, Lassam NJ, Hayward NK, Hogg D, Narod SA, Foulkes WD. Sun S, et al. Among authors: hayward nk. Int J Cancer. 1997 Nov 14;73(4):531-6. doi: 10.1002/(sici)1097-0215(19971114)73:4<531::aid-ijc13>3.0.co;2-c. Int J Cancer. 1997. PMID: 9389568 Free article.

8

Haplotype analysis of two recurrent CDKN2A mutations in 10 melanoma families: evidence for common founders and independent mutations.

Pollock PM, Spurr N, Bishop T, Newton-Bishop J, Gruis N, van der Velden PA, Goldstein AM, Tucker MA, Foulkes WD, Barnhill R, Haber D, Fountain J, Hayward NK. Pollock PM, et al. Among authors: hayward nk. Hum Mutat. 1998;11(6):424-31. doi: 10.1002/(SICI)1098-1004(1998)11:6<424::AID-HUMU2>3.0.CO;2-2. Hum Mutat. 1998. PMID: 9603434

9

Evidence for three tumor suppressor loci on chromosome 9p involved in melanoma development.

Pollock PM, Welch J, Hayward NK. Pollock PM, et al. Among authors: hayward nk. Cancer Res. 2001 Feb 1;61(3):1154-61. Cancer Res. 2001. PMID: 11221846

10

PTEN inactivation is rare in melanoma tumours but occurs frequently in melanoma cell lines.

Pollock PM, Walker GJ, Glendening JM, Que Noy T, Bloch NC, Fountain JW, Hayward NK. Pollock PM, et al. Among authors: hayward nk. Melanoma Res. 2002 Dec;12(6):565-75. doi: 10.1097/00008390-200212000-00006. Melanoma Res. 2002. PMID: 12459646

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

421 results

Search Page